ARRAY BIOPHARMA INC's ticker is and the CUSIP is 04269XAA3.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $5,808,000 | -79.3% | 3,215,000 | -84.5% | 0.06% | -82.1% |
| Q2 2017 | $28,081,000 | +5.9% | 20,715,000 | +10.7% | 0.36% | -13.3% |
| Q1 2017 | $26,515,000 | +23.6% | 18,715,000 | +22.7% | 0.41% | +48.7% |
| Q4 2016 | $21,453,000 | +60.4% | 15,250,000 | +36.9% | 0.28% | +38.5% |
| Q3 2016 | $13,378,000 | +21.0% | 11,139,000 | -14.1% | 0.20% | +19.0% |
| Q2 2016 | $11,052,000 | +33.2% | 12,964,000 | +24.3% | 0.17% | -28.8% |
| Q1 2016 | $8,297,000 | -32.3% | 10,430,000 | -19.3% | 0.24% | -10.6% |
| Q4 2015 | $12,257,000 | -4.9% | 12,930,000 | -2.4% | 0.26% | -13.2% |
| Q3 2015 | $12,891,000 | -23.7% | 13,250,000 | 0.0% | 0.30% | -20.6% |
| Q2 2015 | $16,890,000 | +1.6% | 13,250,000 | 0.0% | 0.38% | +15.7% |
| Q1 2015 | $16,630,000 | +35.0% | 13,250,000 | 0.0% | 0.33% | +37.9% |
| Q4 2014 | $12,321,000 | +6.4% | 13,250,000 | 0.0% | 0.24% | -0.8% |
| Q3 2014 | $11,583,000 | -13.5% | 13,250,000 | 0.0% | 0.24% | -17.4% |
| Q2 2014 | $13,390,000 | -3.3% | 13,250,000 | 0.0% | 0.29% | -1.0% |
| Q1 2014 | $13,843,000 | -0.3% | 13,250,000 | 0.0% | 0.30% | +7.6% |
| Q4 2013 | $13,880,000 | +12.3% | 13,250,000 | +24.0% | 0.28% | 0.0% |
| Q3 2013 | $12,364,000 | +160.1% | 10,685,000 | +113.7% | 0.28% | +125.4% |
| Q2 2013 | $4,754,000 | – | 5,000,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|